Difference between revisions of "Carmustine (BCNU)"
m (moved Carmustine (Bicnu) to Carmustine (BiCNU)) |
|||
| Line 7: | Line 7: | ||
==Patient drug information== | ==Patient drug information== | ||
| + | *[http://chemocare.com/bio/carmustine.asp Carmustine (Bicnu) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/carmustine.asp Carmustine (Bicnu) patient drug information (Chemocare)]</ref> | ||
*[http://www.uptodate.com/contents/carmustine-patient-drug-information Carmustine (Bicnu) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/carmustine-patient-drug-information Carmustine (Bicnu) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/carmustine-patient-drug-information Carmustine (Bicnu) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/carmustine-patient-drug-information Carmustine (Bicnu) patient drug information (UpToDate)]</ref> | ||
Revision as of 19:00, 5 December 2011
General information
Class/mechanism: Nitrosourea, alkylates DNA and RNA, inhibits several key enzymatic processes by carbamoylation of amino acids in proteins.[1][2]
Route: IV
Extravasation: vesicant/irritant
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert[1].
Patient drug information
- Carmustine (Bicnu) patient drug information (Chemocare)[3]
- Carmustine (Bicnu) patient drug information (UpToDate)[4]
Regimens
Standard format will be:
<acronym (if any)> <generic drug1, generic drug2, generic drug3, etc.> (disease)